Upon regulatory success in EU and US assuming a 5 per 100k incidence of IIH at 50% market penetration and 10 per 100k prevalence of IIH at 20% market penetration I had done some numbers at a peak sales multiple of 3x that this would be worth about 2.5bil. Obviously a long way from there and I doubt it will make it that far but I don't see anything south of 500m as a reasonable buyout assuming regulatory approval in EU. Just a forecast, anyway.
- Forums
- ASX - By Stock
- IXC
- Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-153
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.260M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28320 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28320 | 0.070 |
1 | 7250 | 0.069 |
1 | 100000 | 0.066 |
1 | 100000 | 0.065 |
1 | 84879 | 0.063 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 5000 | 1 |
0.072 | 22452 | 2 |
0.080 | 5000 | 1 |
0.085 | 8805 | 1 |
0.090 | 126146 | 1 |
Last trade - 11.06am 04/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable